Skip to main content

Man Group Enjoys Inflows, Positive Investment Performance In Q3 2020

Listed investment manager Man Group published its Q3 trading statement today, showing that, overall, funds under management increased from $108bn at the end of Q2 to $113bn in Q3, driven by net inflows of $1.7bn and positive investment performance.

The firm's alternatives business line delivered net inflows of $1.9bn. Both the absolute return and total return product lines showed increased inflows of $0.2bn and $2.0bn respectively, with the multi-manager offerings seeing net outflows of -$0.3bn in the quarter.

"Net inflows of $1.9 billion were driven by AHL TargetRisk and Alternative Risk Premia. In response to client demand globally, we are expanding our AHL TargetRisk product category with additional product launches expected in Q4. Positive investment performance of $0.3 billion was delivered across various strategies including positive absolute performance from AHL TargetRisk (+2.5%) and AHL Evolution (+1.9%). This was partly offset by negative absolute performance from Alternative Risk Premia (-3.2%," says the statement.

In the three years to September 30 2020, the only Man Group product delivering negative returns is the GLG European Long Short Fund, which is negligible at -0.1%, an estimated number in the statement., although the product's five year annualised return is positive at +1.2%. AHL TargetRisk is the best performing product, both at the 3-year annualised level (+10.5%) and the 5-year annualised level (+10.9%), in Man Group's alternatives portfolio.


© The Sortino Group Ltd

All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency or other Reprographic Rights Organisation, without the written permission of the publisher. For more information about reprints from AlphaWeek, click here.